Concourse Financial Group Securities, Inc. Akebia Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$0.94 - $1.55 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$0.86 - $1.63 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$1.27 - $2.24 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$0.8 - $1.28 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$0.87 - $1.84 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$0.87 - $1.84 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$0.51 - $1.43 $0 - $0
Q1 2023 May 15, 2023	BUY	$0.56 - $1.15 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$0.25 - $0.58 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$0.3 - $0.46 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$0.32 - $0.67 $0 - $0
Q1 2022 May 09, 2022	BUY	$0.72 - $2.93 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$2.26 - $3.34 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$2.35 - $3.88 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$2.83 - $4.2 $0 - $0
Q1 2021 May 13, 2021	BUY	$2.92 - $5.06 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$2.22 - $3.78 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$2.39 - $13.08 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$6.67 - $13.58 $0 - $0
Q1 2020 May 13, 2020	BUY	$4.1 - $10.24 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$3.16 - $6.73 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$3.55 - $5.4 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$4.1 - $8.05 $0 - $0
Q1 2019 May 15, 2019	BUY	$5.41 - $8.73 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$5.39 - $9.15 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$7.44 - $10.65 $0 - $0

Others Institutions Holding AKBA

# of Institutions

110

Shares Held

55M

Call Options Held

554K

Put Options Held

246K

Black Rock Inc. New York, NY

11.6M
Shares

$21.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

9.28M
Shares

$17.3 Million
0.0% of portfolio
Satter Management Co., L.P.

5.75M
Shares

$10.7 Million
11.5% of portfolio
Geode Capital Management, LLC Boston, MA

4.54M
Shares

$8.48 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

4.06M
Shares

$7.6 Million
0.01% of portfolio

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $344M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account